Startup profile for Benchling: latest funding, latest known valuation, total disclosed funding, investors, status, sources, and why the company is interesting. Part of the Venture Capital Tracker startup directory.
Venture Capital Tracker logo
Venture Capital Tracker

Startup profile · funding coverage

Benchling funding, valuation and investors

R&D cloud platform — the operating system for life science labs.

Keep track of Benchling

Save this profile to your VCT watchlist for a quick return.

View watchlist

Funding, valuation & investors

Answer-first snapshot

Latest funding

Series F

$100M · November 2021

Latest known valuation

Not publicly disclosed

Total disclosed equity funding

$4.1B

Excludes debt, grants, acquisitions, secondaries, and IPO proceeds.

Current status

private

growth · San Francisco, California

Sources: latest funding: Series F (Nov 2021): $100M at $6.1B co-led by Franklin Templeton and Altimeter; Tiger Global, Lone Pine joined (Benchling press) Last verified: 2026-07-25

Overview

Benchling provides a cloud platform for life science R&D, including electronic lab notebooks, molecular biology tools, sample tracking, and workflow management. It is widely adopted by biotech and pharma companies as the digital backbone for research operations.

Why Benchling is interesting

Benchling is the SaaS system of record for biotech R&D — from a16z seed to $6.1B valuation with Sequoia, Altimeter, and Tiger Global in the syndicate.

Product & use cases

Benchling provides a cloud platform for life science R&D, including electronic lab notebooks, molecular biology tools, sample tracking, and workflow management.

  • Enterprise platform deployment for core workflows

Key facts

  • Series F (Nov 2021): $100M at $6.1B co-led by Franklin Templeton and Altimeter; Tiger Global, Lone Pine joined (Benchling press)
  • Series E (Apr 2021): led by Sequoia at $4B valuation (Bloomberg)
  • Product: ELN, molecular biology tools, sample tracking for biotech/pharma R&D (Benchling site)
  • Co-investors not in VCT directory: Franklin Templeton, Lone Pine Capital

Funding history (newest first)

Series F

Nov 2021 $100M

Source: Series F (Nov 2021): $100M at $6.1B co-led by Franklin Templeton and Altimeter; Tiger Global, Lone Pine joined (Benchling press)

Series E

Apr 2021 $4B

Source: Series E (Apr 2021): led by Sequoia at $4B valuation (Bloomberg)

Investors in our directory

Funds linked from Benchling's profile — open a fund page for stage focus and related deal articles.

Altimeter Capital Andreessen Horowitz Sequoia Capital Tiger Global Management

Competitive landscape

Edge: Benchling is the SaaS system of record for biotech R&D — from a16z seed to $6.1B valuation with Sequoia, Altimeter, and Tiger Global in the syndicate.

Benchling competes in biotech-life-sciences, enterprise-saas. Incumbents have distribution; startup edge depends on product depth and buyer references. See competitors for specific tradeoffs — no invented market share claims.

  • Veeva incumbent

    Life sciences cloud incumbent.

  • Dotmatics adjacent

    R&D informatics.

  • Salesforce incumbent

    Enterprise platform incumbent.

  • Microsoft incumbent

    Platform bundling competitor.

Notable stories

  • Series F (Nov 2021): $100M at $6.1B co-led by Franklin Templeton and Altimeter; Tiger Global, Lone Pine joined (Benchling press)
  • Series E (Apr 2021): led by Sequoia at $4B valuation (Bloomberg)

Industries

Biotech & Life Sciences Enterprise SaaS

FAQs about Benchling

Practical answers founders, operators, and investors typically search for.

Benchling provides a cloud platform for life science R&D, including electronic lab notebooks, molecular biology tools, sample tracking, and workflow management.
Directory-linked investors include /fund/altimeter-capital, /fund/andreessen-horowitz, /fund/sequoia, /fund/tiger-global-management.
growth stage, private status. Series F (Nov 2021): $100M at $6.1B co-led by Franklin Templeton and Altimeter; Tiger Global, Lone Pine joined (Benchling press)
Private as of July 2026 (status: private).
See fundraisingRounds for verified dates and disclosed amounts.
See competitors section — named alternatives with honest positioning notes.
Not publicly disclosed unless noted in highlights.
San Francisco, California
Website All startups Funding news

By Venture Capital Tracker

Last updated:

Editorial note: AI tools assisted with research, structure, or drafting. Venture Capital Tracker retains human editorial responsibility for factual accuracy, relevance, and source quality before publication.